Luisa Piccin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Polyomavirus and related diseases
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 6
- Cutaneous Melanoma Detection and Management 4
- Polyomavirus and related diseases 2
- COVID-19 and healthcare impacts 1
-
- Melanoma and MAPK Pathways 8
- Co-authors
- Vanna Chiarion‐Sileni (10 shared papers)Jacopo Pigozzo (11 shared papers)Simone Mocellin M. D (6 shared papers)Luca Giovanni Campana (2 shared papers)Sara Valpione (2 shared papers)Sandro Pasquali (2 shared papers)Elide Matano (2 shared papers)Rosa Fonti (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Translational Medicine (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Luisa Piccin
19 papers receiving 356 citations
Peers
Comparison fields: 5 of 39
- Oncology 243
- Cancer Research 21
- Pulmonary and Respiratory Medicine 39
- Radiology, Nuclear Medicine and Imaging 23
- Molecular Biology 44
Countries citing papers authored by Luisa Piccin
This map shows the geographic impact of Luisa Piccin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Piccin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Piccin more than expected).
Fields of papers citing papers by Luisa Piccin
This network shows the impact of papers produced by Luisa Piccin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Piccin. The network helps show where Luisa Piccin may publish in the future.
Co-authors
The 25 scholars most cited alongside Luisa Piccin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 167 | |
| 2 | 2024 | 54 | |
| 3 | 2019 | 40 | |
| 4 | 2024 | 19 | |
| 5 | 2020 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2024 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2024 | 8 | |
| 10 | 2022 | 5 | |
| 11 | 2023 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2025 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2015 | 0 |
About Luisa Piccin
Luisa Piccin is a scholar working on Oncology, Molecular Biology, Ophthalmology, Cancer Research and Environmental Chemistry, having authored 26 papers that have together received 361 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cutaneous Melanoma Detection and Management (4 papers), Polyomavirus and related diseases (2 papers), Cancer Genomics and Diagnostics (2 papers), Ocular Oncology and Treatments (2 papers), Lung Cancer Diagnosis and Treatment (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Oncology (243 citations), Cancer Research (21 citations), Pulmonary and Respiratory Medicine (39 citations), Radiology, Nuclear Medicine and Imaging (23 citations) and Molecular Biology (44 citations). Luisa Piccin has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Vanna Chiarion‐Sileni, Jacopo Pigozzo, Simone Mocellin M. D, Luca Giovanni Campana, Sara Valpione, Sandro Pasquali, Elide Matano, Rosa Fonti, Sabino De Placido and Vincenzo Damiano. Their work appears in journals such as Frontiers in Oncology, International Journal of Molecular Sciences, Journal of Translational Medicine, Journal for ImmunoTherapy of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.